Combination of Biochar and Advanced Oxidation Processes for the Sustainable Elimination of Pharmaceuticals in Water DOI Open Access
Carolina Gallego-Ramírez, Edwin Chica, Ainhoa Rubio-Clemente

et al.

Sustainability, Journal Year: 2024, Volume and Issue: 16(23), P. 10761 - 10761

Published: Dec. 8, 2024

The presence of pharmaceuticals in aquatic ecosystems is an issue increasing concern. Regardless the low concentration water, they can have a toxic effect on both humans and organisms. Advanced oxidation processes (AOPs) been described as promising technique for eliminating due to their high efficiency. However, cost associated with application these reagents energy requirements affected implementation AOPs at large scales. Biochar has suggested be used catalyst overcome limitations. considered alternative heterogeneous thanks its physicochemical characteristics like specific surface area, porous structure, oxygen-containing functional groups, electrical conductivity, persistent free radicals (PFRs), modifiable properties, structure defects. This carbonaceous material presents capacity activate oxidizing agents leading formation radical species, which are needed degrade pharmaceuticals. Additionally, AOP/biochar systems destroy pharmaceutical molecules following non-radical pathway. To enhance biochar catalytic performance, modifications such iron (Fe) impregnation, heteroatom doping, supporting semiconductors surface. Although efficiently combination several mineralization from further research must conducted evaluate different regeneration techniques increase biochar’s sustainable applicability reduce operational combined process. Moreover, conditions influencing system required evaluated discern find that maximize degradation by systems.

Language: Английский

Integrating environmental effects in the benefit-risk assessment of therapeutic products: a proposal and example for sustainable health and healthcare DOI Creative Commons

Emiliano Giovagnoni,

Luisa Mattoli,

Andrea Cossu

et al.

Frontiers in Drug Safety and Regulation, Journal Year: 2025, Volume and Issue: 4

Published: Jan. 17, 2025

To mitigate healthcare’s unintended effects, environmental risk data such as ecotoxicity and contamination need to be considered by all stakeholders in the healthcare value chain. As decision-makers educators, providers are a unique position make delivery more sustainable. However, current benefit-risk assessments of therapeutic products do not systematically include data. The purpose this paper was review literature regulatory context propose expanding an evidence-based evaluation impact inform decision-making. Our findings indicate that broadened aspects excipients, synergistic effects contaminants, risks humans (e.g., drinking water). Concrete proposals improve guidelines for assessment already exist. Open access databases on substances used human consumption available. European Union Regulation Medical Devices provides basis approach developing sustainable based natural substances. Based this, here promoted decision scheme (and other stakeholders) involves comparing clinical safety efficacy products; data; then deciding. A case example involving treatment patients with gastroesophageal reflux dyspepsia is presented. We provide suggestions integrating persistence into practice. Expanding during decision-making way achieve healthier outcome all.

Language: Английский

Citations

0
Recent occurrence of pharmaceuticals in freshwater, emerging treatment technologies, and future considerations: A review DOI Creative Commons
Ojima Z. Wada, David B. Olawade

Chemosphere, Journal Year: 2025, Volume and Issue: 374, P. 144153 - 144153

Published: Feb. 12, 2025

Language: Английский

Citations

0
Evolution of the Environmental Impact Assessment Process in Romania in the Context of Sustainable Development DOI Creative Commons

Madalina Elena Abalasei,

Daniela Fighir, Carmen Teodosiu

et al.

Applied Sciences, Journal Year: 2025, Volume and Issue: 15(7), P. 3777 - 3777

Published: March 30, 2025

Environmental Impact Assessment (EIA) is a required systematic process of identifying, predicting, and assessing the environmental effects proposed actions projects such as nuclear power stations, long-distance railways, motorways, express roads, waste disposal installations for hazardous waste, dams certain capacity. After presenting EIA evolution at international level, its introduction into Romanian legislation in 1973 discussed, considering criticism regarding main problems arising from widespread implementation. Although some studies have included state-of-the-art synthesis effectiveness concept, there are no reported using bibliometric analysis to describe detail historical development process. The aim this study analyze Romania context sustainable (SD). To achieve objective, data obtained implementation PRISMA methodology were considered. For purpose, 125 publications on selected, review Elsevier, Scopus, Springer databases period 2000–2024. research results provide practical recommendations decision-makers practitioners Romania, aiming strengthen practices with purpose ensuring effective principles.

Language: Английский

Citations

0
Enhanced catalytic degradation of acetaminophen using magnesium oxide-infused clay with ultrasonic activation of hydrogen peroxide DOI Creative Commons

Roshana Rashidi,

Seyed Hamed Meraji, Amin Mahmoudi

et al.

Arabian Journal of Chemistry, Journal Year: 2024, Volume and Issue: 17(12), P. 106047 - 106047

Published: Nov. 6, 2024

Language: Английский

Citations

0
Combination of Biochar and Advanced Oxidation Processes for the Sustainable Elimination of Pharmaceuticals in Water DOI Open Access
Carolina Gallego-Ramírez, Edwin Chica, Ainhoa Rubio-Clemente

et al.

Sustainability, Journal Year: 2024, Volume and Issue: 16(23), P. 10761 - 10761

Published: Dec. 8, 2024

The presence of pharmaceuticals in aquatic ecosystems is an issue increasing concern. Regardless the low concentration water, they can have a toxic effect on both humans and organisms. Advanced oxidation processes (AOPs) been described as promising technique for eliminating due to their high efficiency. However, cost associated with application these reagents energy requirements affected implementation AOPs at large scales. Biochar has suggested be used catalyst overcome limitations. considered alternative heterogeneous thanks its physicochemical characteristics like specific surface area, porous structure, oxygen-containing functional groups, electrical conductivity, persistent free radicals (PFRs), modifiable properties, structure defects. This carbonaceous material presents capacity activate oxidizing agents leading formation radical species, which are needed degrade pharmaceuticals. Additionally, AOP/biochar systems destroy pharmaceutical molecules following non-radical pathway. To enhance biochar catalytic performance, modifications such iron (Fe) impregnation, heteroatom doping, supporting semiconductors surface. Although efficiently combination several mineralization from further research must conducted evaluate different regeneration techniques increase biochar’s sustainable applicability reduce operational combined process. Moreover, conditions influencing system required evaluated discern find that maximize degradation by systems.

Language: Английский

Citations

0